Involvement of heparanase in tumor metastases: a new target in cancer therapy?
Boyd
Douglas D
DD
Nakajima
Motowo
M
D000230:Adenocarcinoma / Q000378:metabolism / Q000473:pathology; D043925:Angiogenesis Inducing Agents / Q000378:metabolism; D001485:Basement Membrane / Q000201:enzymology / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005966:Glucuronidase / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D006133:Growth Substances / Q000378:metabolism; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis / Q000473:pathology / Q000503:physiopathology*; D016337:RNA, Catalytic; D014162:Transfection; D000099175:Heparanase
D043925:Angiogenesis Inducing Agents; D004791:Enzyme Inhibitors; D005966:Glucuronidase; D006133:Growth Substances; D006497:Heparan Sulfate; D016337:RNA, Catalytic; D000099175:Heparanase